A new kind of patient advocate
July 30, 2008Sales and Marketing Cancer, campaigner, market access, patient
When I came to interview Kate Spall, it was she, not I, who fired the first few questions. Her approach …
Scepticism over
July 29, 2008NICE will receive a record £100 million from the government in attempt to end the UK's postcode lottery and speed …
The organisational generation gap
July 28, 2008Business Services careers, generations, recruitment
If you look at your organisation carefully, it is likely you will find three or even four generations represented among …
Latest news from Datamonitor
July 28, 2008Sales and Marketing Genentech, Roche
Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …
Pharma-Patient group relationships
July 24, 2008Research and Development, Sales and Marketing industry relations, patient groups, pharma
In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …
Generics giant formed as Teva acquires Barr
July 24, 2008Sales and Marketing generics
Teva is to buy rival firm Barr for $7.5 billion to create a new giant in the global generics industry. …
Roche acquires gene therapy specialists Mirus
July 24, 2008Sales and Marketing
Roche has bought Mirus Bio for $125 million, a move which it believes will put it at the forefront of …
Pfizer thrives despite US slowdown
July 24, 2008Sales and Marketing
Pfizer has posted strong second quarter results despite underwhelming performance from its US operations. Outside the US Pfizer's revenue rose …
National movement’ needed to tackle obesity
July 24, 2008Local communities, businesses, charities and other groups need to come together in a 'national movement' in order to tackle the …
Latest news from Datamonitor
July 21, 2008Sales and Marketing
Immunisation against S. aureus has potential in selected target groups Staphylococcus aureus bacteria have become a key concern in both …
Novartis shows strong Q2 growth
July 17, 2008Sales and Marketing
Novartis has surpassed estimates for its second quarter performance, boosted by higher than expected sales of its flagship cardiovascular and …
AstraZeneca staff trained in new Code of Conduct
July 17, 2008Medical Communications
AstraZeneca is training staff in a new Code of Conduct that aims to ensure employees at all levels and locations …
US pharma marketing Code updated
July 17, 2008Medical Communications, Sales and Marketing
Dining out, staff training and medical education are among the major issues under the microscope in the US industry association …
GSK signs $1.5 billion insomnia collaboration
July 16, 2008Sales and Marketing Actelion, GSK, insomnia
GlaxoSmithKline has joined forces with Swiss biopharmaceutical company Actelion to bring a new insomnia treatment to market.The deal could be …
The PPRS: A Happy Compromise
July 16, 2008Sales and Marketing
After more than a year of uncertainty and months of tense negotiation, the ABPI looks to have secured a very …
PPRS reaction
July 16, 2008Research and Development, Sales and Marketing biotech
Aisling Burnand, chief executive of the biotech representative body the BIA welcomed the deal, saying she was pleased the "months …
Relief as pharma industry secures ‘pro-innovation’ UK pricing deal
July 16, 2008Sales and Marketing ABPI, par
Agreement has been reached on a new UK medicines pricing deal which safeguards the industry's ability to set its own …
Roche suspended from ABPI
July 15, 2008Sales and Marketing
Roche has been suspended from the ABPI for at least six months after being found guilty of bringing discredit on …
